| [1] | Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gulmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65. doi: 10.1016/S0140-6736(13)62229-1. pmid:24411644
|
| [2] | Fleurence RL, Torgerson DJ. Setting priorities for research. Health policy. 2004;69(1):1–10. pmid:15484602 doi: 10.1016/j.healthpol.2003.11.002
|
| [3] | Michaud CM, Murray CJ, Bloom BR. Burden of disease—implications for future research. Jama. 2001;285(5):535–9. pmid:11176854 doi: 10.1001/jama.285.5.535
|
| [4] | Phelps CE, Parente ST. Priority setting in medical technology and medical practice assessment. Medical care. 1990;28(8):703–23. pmid:2117223 doi: 10.1097/00005650-199008000-00004
|
| [5] | Buxton M, Hanney S. How can payback from health services research be assessed? Journal of health services research & policy. 1996;1(1):35–43. pmid:10180843
|
| [6] | Davies L, Drummond M, Papanikolaou P. Prioritizing investments in health technology assessment. Can we assess potential value for money? International journal of technology assessment in health care. 2000;16(1):73–91. pmid:10815355 doi: 10.1017/s0266462300016172
|
| [7] | Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. PharmacoEconomics. 2006;24(11):1055–68. pmid:17067191 doi: 10.2165/00019053-200624110-00003
|
| [8] | Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health economics. 1996;5(6):513–24. pmid:9003938 doi: 10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9
|
| [9] | Howard RA. Information Value Theory. IEEE Transactions on Systems Science and Cybernetics; 1966. doi: 10.1109/tssc.1966.300074
|
| [10] | Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. West Sussex: Wiley; 2004.
|
| [11] | Guide to the methods of technology appraisal. NICE; 2013. .
|
| [12] | Mohseninejad L, van Baal PH, van den Berg M, Buskens E, Feenstra T. Value of information analysis from a societal perspective: a case study in prevention of major depression. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2013;16(4):490–7. doi: 10.1016/j.jval.2012.12.007. pmid:23796282
|
| [13] | Holmes D. Report triggers quibbles over QALYs, a staple of health metrics. Nature medicine. 2013;19(3):248. doi: 10.1038/nm0313-248. pmid:23467219
|
| [14] | Bojke L, Claxton K, Sculpher MJ, Palmer S. Identifying research priorities: the value of information associated with repeat screening for age-related macular degeneration. Medical decision making: an international journal of the Society for Medical Decision Making. 2008;28(1):33–43. doi: 10.1177/0272989X07309638. . pmid:18263560
|
| [15] | Dong H, Coyle D, Buxton M. Value of information analysis for a new technology: computer-assisted total knee replacement. International journal of technology assessment in health care. 2007;23(3):337–42. pmid:17579936 doi: 10.1017/s0266462307070419
|
| [16] | Micieli A, Bennell MC, Pham B, Krahn M, Singh SM, Wijeysundera HC. Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation. Journal of the American Heart Association. 2014;3(5):e001031. doi: 10.1161/JAHA.114.001031. pmid:25227405
|
| [17] | Tuffaha HW, Gordon LG, Scuffham PA. Value of information analysis in oncology: the value of evidence and evidence of value. Journal of oncology practice / American Society of Clinical Oncology. 2014;10(2):e55–62. doi: 10.1200/JOP.2013.001108. pmid:24194511
|
| [18] | Woods B, Veenstra D, Hawkins N. Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2011;14(8):989–1001. doi: 10.1016/j.jval.2011.05.048. pmid:22152167
|
| [19] | Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2015. .
|
| [20] | Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–43. doi: 10.1016/S0140-6736(09)61303-9. pmid:19716966
|
| [21] | Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, et al. Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Medical decision making: an international journal of the Society for Medical Decision Making. 2013;33(4):463–71. doi: 10.1177/0272989X13484388. pmid:23635833
|
| [22] | Wald HL, Leykum LK, Mattison ML, Vasilevskis EE, Meltzer DO. Road map to a patient-centered research agenda at the intersection of hospital medicine and geriatric medicine. Journal of general internal medicine. 2014;29(6):926–31. doi: 10.1007/s11606-014-2777-1. pmid:24557516
|
| [23] | Heath A MI, Baio G. A Review of Methods for the Analysis of the Expected Value of Information. Pre-publication manuscript arXiv:150702513 [statAP]; 2015. .
|
| [24] | Strong M, Oakley JE, Brennan A. Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach. Medical decision making: an international journal of the Society for Medical Decision Making. 2014;34(3):311–26. doi: 10.1177/0272989X13505910. pmid:24246566
|
| [25] | Welton NJ, Thom HH. Value of Information: We've Got Speed, What More Do We Need? Medical decision making: an international journal of the Society for Medical Decision Making. 2015;35(5):564–6. doi: 10.1177/0272989X15579164. pmid:25840903
|
